NSB 12.8% 3.4¢ neuroscientific biopharmaceuticals ltd

Ann: Positive Results in Multiple Sclerosis Study, page-12

  1. 1,121 Posts.
    lightbulb Created with Sketch. 886
    (22 BILLION DOLLAR INDUSTRY FOR MULTIPLE SCHLEROSIS]]) on top of what we allready have,GLAUCOMA,,,,DEMENTIA,,,,,COVID LUNG REPAIR,,,,we are getting close to a 100 BILLION DOLLAR DRUG,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TAKEOVER IMMINENT,and imho over 3.50 a share
 
watchlist Created with Sketch. Add NSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.